Allmed Medical Products Co Ltd Class A Tangible Net Worth Ratio
Allmed Medical Products Co Ltd Class A tangible net worth ratio. Allmed Medical Products Co Ltd Class A (002950) has a Tangible Net Worth Ratio of 94.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥220.68 Million) from net assets (CN¥3.72 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Allmed Medical Products Co Ltd Class A growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Allmed Medical Products Co Ltd Class A (2014–2025)
Tangible net worth ratio of Allmed Medical Products Co Ltd Class A from 2014 to 2025. This chart shows how Allmed Medical Products Co Ltd Class A's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 94.1%, reflecting net assets of CN¥3.72 Billion with intangible assets of CN¥220.68 Million CNY. Check 002950 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Allmed Medical Products Co Ltd Class A Tangible Net Worth Ratio by Year (2014–2025)
Allmed Medical Products Co Ltd Class A tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Allmed Medical Products Co Ltd Class A from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Allmed Medical Products Co Ltd Class A (002950) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.8% | CN¥3.61 Billion | CN¥225.10 Million | CN¥5.61 Billion | ▼ -0.9 pp |
| 2024 | 94.7% | CN¥3.45 Billion | CN¥182.78 Million | CN¥5.06 Billion | ▲ +1.0 pp |
| 2023 | 93.7% | CN¥3.21 Billion | CN¥202.66 Million | CN¥5.08 Billion | ▲ +0.5 pp |
| 2022 | 93.2% | CN¥3.13 Billion | CN¥213.58 Million | CN¥5.75 Billion | ▲ +1.7 pp |
| 2021 | 91.5% | CN¥2.75 Billion | CN¥234.75 Million | CN¥5.00 Billion | ▼ -1.0 pp |
| 2020 | 92.5% | CN¥2.92 Billion | CN¥219.53 Million | CN¥4.86 Billion | ▲ +0.3 pp |
| 2019 | 92.2% | CN¥2.06 Billion | CN¥161.23 Million | CN¥3.16 Billion | ▲ +6.2 pp |
| 2018 | 86.0% | CN¥1.32 Billion | CN¥184.81 Million | CN¥2.90 Billion | ▲ +3.2 pp |
| 2017 | 82.8% | CN¥1.10 Billion | CN¥188.83 Million | CN¥2.27 Billion | ▼ -6.3 pp |
| 2016 | 89.1% | CN¥1.02 Billion | CN¥111.36 Million | CN¥1.90 Billion | ▲ +0.3 pp |
| 2015 | 88.8% | CN¥994.18 Million | CN¥111.84 Million | CN¥1.85 Billion | ▼ -0.9 pp |
| 2014 | 89.7% | CN¥742.08 Million | CN¥76.67 Million | CN¥1.75 Billion | — |